Literature DB >> 7477669

Effect of chronic administration of phenytoin on regional monoamine levels in rat brain.

M H Meshkibaf1, M N Subhash, K M Lakshmana, B S Rao.   

Abstract

Phenytoin (DPH) is a widely used anticonvulsant drug but a conclusive mode of action is not yet clear. This study was undertaken to assess the effects of chronic administration of DPH on monoamine levels. DPH (50 mg/kg body weight) was administered to adult male Wistar rats by intraperitoneal injections for 45 days and the regional brain levels of norepinephrine (NE), dopamine (DA) and serotonin (5-HT) were assayed using high performance liquid chromatographic (HPLC) method. The experimental rats revealed no behavioral deficits of any kind nor body and brain weight deficits were observed. Increased NE levels were observed after DPH administration in motor cortex (P < 0.05), striatum-accumbens (P < 0.01) and hippocampus (P < 0.01), whereas, NE level was decreased in brain stem (P < 0.05). DA levels were increased in striatum-accumbens (P < 0.05), hypothalamus (P < 0.001) and cerebellum (P < 0.001) but decreased in brainstem (P < 0.01). In DPH treated rats, 5-HT levels were increased in motor cortex (P < 0.001) but decreased in cerebellum (P < 0.001) when compared to control group of rats. The present study suggest that chronic administration of DPH induces alterations in monoamine levels in specific brain regions. DPH seems to mediate its anticonvulsant action by selectively altering the monoamine levels in different brain regions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7477669     DOI: 10.1007/bf00969688

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  37 in total

1.  Distribution of diphenylhydantoin in rat organs: study with neuron-glia and subcellular fractions.

Authors:  T Yanagihara; A Hamberger
Journal:  J Pharmacol Exp Ther       Date:  1971-12       Impact factor: 4.030

2.  Alterations of the cortical noradrenergic system in chronic cobalt epileptogenic foci in the rat: a histofluorescent and biochemical study.

Authors:  S Trottier; B Berger; P Chauvel; J Dedek; M Gay
Journal:  Neuroscience       Date:  1981       Impact factor: 3.590

3.  Effects of acute and chronic barbiturate administration on synaptosomal calcium accumulation.

Authors:  M G Ondrusek; J K Belknap; S W Leslie
Journal:  Mol Pharmacol       Date:  1979-03       Impact factor: 4.436

4.  Sodium channel binding and anticonvulsant activities of hydantoins containing conformationally constrained 5-phenyl substituents.

Authors:  W J Brouillette; G B Brown; T M DeLorey; G Liang
Journal:  J Pharm Sci       Date:  1990-10       Impact factor: 3.534

5.  Relationships between plasma concentrations of diphenylhydantoin, phenobarbital, carbamazepine, and 3-sulfamoylmethyl-1,2-benzisoxazole (AD-810), a new anticonvulsant agent, and their anticonvulsant or neurotoxic effects in experimental animals.

Authors:  Y Masuda; Y Utsui; Y Shiraishi; T Karasawa; K Yoshida; M Shimizu
Journal:  Epilepsia       Date:  1979-12       Impact factor: 5.864

6.  Cerebrospinal fluid and serum levels of dopa, catechols, and monoamine metabolites in patients with epilepsy.

Authors:  O Devinsky; S Emoto; D S Goldstein; R Stull; R J Porter; W H Theodore; N S Nadi
Journal:  Epilepsia       Date:  1992 Mar-Apr       Impact factor: 5.864

7.  Dopaminergic supersensitivity after long-term administration of phenytoin in rats.

Authors:  R Lalonde
Journal:  Epilepsia       Date:  1985 Jan-Feb       Impact factor: 5.864

8.  Sodium valproate induced alterations in monoamine levels in different regions of the rat brain.

Authors:  M H Baf; M N Subhash; K M Lakshmana; B S Rao
Journal:  Neurochem Int       Date:  1994-01       Impact factor: 3.921

9.  Spontaneous recurrent seizures in rats: amino acid and monoamine determination in the hippocampus.

Authors:  E A Cavalheiro; M J Fernandes; L Turski; M G Naffah-Mazzacoratti
Journal:  Epilepsia       Date:  1994 Jan-Feb       Impact factor: 5.864

10.  Carbamazepine decreases catecholamine turnover in the rat brain.

Authors:  P C Waldmeier; P A Baumann; B Fehr; P De Herdt; L Maitre
Journal:  J Pharmacol Exp Ther       Date:  1984-10       Impact factor: 4.030

View more
  7 in total

Review 1.  Computational models of neuronal biophysics and the characterization of potential neuropharmacological targets.

Authors:  Michele Ferrante; Kim T Blackwell; Michele Migliore; Giorgio A Ascoli
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

2.  Phenytoin promotes Th2 type immune response in mice.

Authors:  K Okada; T Sugiura; E Kuroda; S Tsuji; U Yamashita
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

3.  Comparative behavioral and neurochemical analysis of phenytoin and valproate treatment on epilepsy induced learning and memory deficit: Search for add on therapy.

Authors:  Awanish Mishra; Rajesh Kumar Goel
Journal:  Metab Brain Dis       Date:  2015-01-23       Impact factor: 3.584

4.  Using cerebral white matter for estimation of nondisplaceable binding of 5-HT1A receptors in temporal lobe epilepsy.

Authors:  Giampiero Giovacchini; Shielah Conant; Peter Herscovitch; William H Theodore
Journal:  J Nucl Med       Date:  2009-10-16       Impact factor: 10.057

Review 5.  Serotonin and sudden unexpected death in epilepsy.

Authors:  Alexandra N Petrucci; Katelyn G Joyal; Benton S Purnell; Gordon F Buchanan
Journal:  Exp Neurol       Date:  2019-12-19       Impact factor: 5.330

6.  Treatment of cardiac arrhythmias in a mouse model of Rett syndrome with Na+-channel-blocking antiepileptic drugs.

Authors:  José A Herrera; Christopher S Ward; Meagan R Pitcher; Alan K Percy; Steven Skinner; Walter E Kaufmann; Daniel G Glaze; Xander H T Wehrens; Jeffrey L Neul
Journal:  Dis Model Mech       Date:  2015-02-20       Impact factor: 5.758

7.  Modafinil and its metabolites enhance the anticonvulsant action of classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model.

Authors:  Dorota Zolkowska; Marta Andres-Mach; Thomas E Prisinzano; Michael H Baumann; Jarogniew J Luszczki
Journal:  Psychopharmacology (Berl)       Date:  2015-02-21       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.